US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 20, 2016 (10 years ago)

Propofol1% 10mg/mL injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Propofol1% 10mg/mL injection, 20 mL BD syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0119-73

Recalling firm
Pharmakon Pharmaceuticals, Inc.
NDC code
45183-0119-73
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1264-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Propofol recalls

See all
Class I · High risk Terminated

PROPOFOL Injectable Emulsion

Reason Presence of particulate matter

Pfizer Inc. NDC 0409-4699-54 D-1540-2022
Class I · High risk Terminated

Propofol Injectable Emulsion

Reason Presence of particulate matter: particulate identified as a beetle.

Pfizer Inc. NDC 0409-4699-54 D-1301-2022
Class II · Moderate risk Terminated

Diprivan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022
Class II · Moderate risk Terminated

Diprivan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022